
Bispecific Antibody Therapy Fact Sheet
This fact sheet contains commonly asked questions and more information on bispecific antibody therapy. Learn more about different treatment options
Year: 2004
Language: Amharic
Author(s): World Federation of Hemophilia
Format: Document
The 2023 edition is available in: English, Spanish, French, Arabic, Russian, Simplified Chinese
This edition is also available in: Japanese
This edition of the resource has also been translated into the following language, with permission from the WFH, by NMOs: Setswana
This is not an official WFH translation. This resource has been translated with permission by a WFH National Member Organization (NMO), and is shared here with their kind permission. Translating organizations are encouraged to have translations reviewed by local experts, the WFH is not responsible for the translation or for any errors or changes to content from the original English edition. Patient organizations interested in translating a WFH resource must first obtain permission from the WFH, available here.
This patient handbook contains basic information about the inheritance, symptoms, and management of hemophilia.

This fact sheet contains commonly asked questions and more information on bispecific antibody therapy. Learn more about different treatment options

This video gives a quick introduction to extended half-life (EHL) clotting factor replacement therapy. Learn more about different treatment options

This video gives a quick introduction to bispecific antibody therapy. Learn more about different treatment options for hemophilia with the

This video gives a quick introduction to standard half-life (SHL) clotting factor replacement therapy. Learn more about different treatment options

This fact sheet contains commonly asked questions and more information on standard half-life (SHL) and extended half-life (EHL) clotting factor

Also Available In: Japanese This resource has also been translated into the following languages, with permission from the WFH, by